-
1
-
-
0031752295
-
Population genetics and molecular epidemiology of Neisseria meningitidis
-
Caugant D.A. Population genetics and molecular epidemiology of Neisseria meningitidis. Apmis 1998, 106:505-525.
-
(1998)
Apmis
, vol.106
, pp. 505-525
-
-
Caugant, D.A.1
-
2
-
-
50249119599
-
Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease
-
Caugant D.A. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect Genet Evol 2008, 8(5):558-565.
-
(2008)
Infect Genet Evol
, vol.8
, Issue.5
, pp. 558-565
-
-
Caugant, D.A.1
-
4
-
-
84871679773
-
New insights in the prevention, diagnosis and treatment of Cryptococcal meningitis
-
Jackson A., van der Host C. New insights in the prevention, diagnosis and treatment of Cryptococcal meningitis. Curr HIV/AIDS Rep 2012, 9(3):267-277.
-
(2012)
Curr HIV/AIDS Rep
, vol.9
, Issue.3
, pp. 267-277
-
-
Jackson, A.1
Van Der Host, C.2
-
5
-
-
14744275348
-
-
WHO Web, [accessed 12/2012]
-
WHO Initiative for vaccine research (IVR) 2012, Web, [accessed 12/2012]. http://www.who.int/vaccine_research/diseases/soa_bacterial/en/index1.html.
-
(2012)
Initiative for vaccine research (IVR)
-
-
-
6
-
-
79957445348
-
Emerging infections programs network: bacterial meningitis in the United States, 1998-2007
-
Thigpen M.C., Whitney G.C., Messonnier N.E., Zell E.R., Lynfield R., Hadler J.L., et al. Emerging infections programs network: bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
-
(2011)
N Engl J Med
, vol.364
, pp. 2016-2025
-
-
Thigpen, M.C.1
Whitney, G.C.2
Messonnier, N.E.3
Zell, E.R.4
Lynfield, R.5
Hadler, J.L.6
-
7
-
-
0141755253
-
Environmental risk and meningitis epidemics in Africa
-
Molesworth A.M., Cuevas L.E., Connor S.J., Morse A.P., Thomson M.C. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 2003, 9:1287-1293.
-
(2003)
Emerg Infect Dis
, vol.9
, pp. 1287-1293
-
-
Molesworth, A.M.1
Cuevas, L.E.2
Connor, S.J.3
Morse, A.P.4
Thomson, M.C.5
-
8
-
-
0019320299
-
Changing patterns of communicable disease in England and Wales. Part I: newly recognized diseases
-
Galbraith N.S., Forbes P., Mayon-White R.T. Changing patterns of communicable disease in England and Wales. Part I: newly recognized diseases. Br Med J 1980, 281(2637):427-430.
-
(1980)
Br Med J
, vol.281
, Issue.2637
, pp. 427-430
-
-
Galbraith, N.S.1
Forbes, P.2
Mayon-White, R.T.3
-
9
-
-
57649220619
-
Factor H and neisserial pathogenesis
-
Welsch J.A., Ram S. Factor H and neisserial pathogenesis. Vaccine 2008, 26(Suppl. 8):140-145.
-
(2008)
Vaccine
, vol.26
, Issue.SUPPL. 8
, pp. 140-145
-
-
Welsch, J.A.1
Ram, S.2
-
10
-
-
0004223773
-
-
McGraw-Hill, NY, p. 650-3
-
Nester E.W., Anderson D.G., Roberts C.E., Nester M.T. Microbiology a human perspective 2009, McGraw-Hill, NY, p. 650-3. 6th ed.
-
(2009)
Microbiology a human perspective
-
-
Nester, E.W.1
Anderson, D.G.2
Roberts, C.E.3
Nester, M.T.4
-
11
-
-
77956636843
-
Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium
-
Sutherland T.C., Quattroni P., Exley R.M., Tang C.M. Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium. Infect Immun 2010, 78(9):3832-3847.
-
(2010)
Infect Immun
, vol.78
, Issue.9
, pp. 3832-3847
-
-
Sutherland, T.C.1
Quattroni, P.2
Exley, R.M.3
Tang, C.M.4
-
12
-
-
78649518588
-
Olfactory nerve-a novel invasion route of Neisseria meningitidis to reach the meninges
-
Sjölinder H., Jonsson A.B. Olfactory nerve-a novel invasion route of Neisseria meningitidis to reach the meninges. PLoS One 2010, 5(11):e14034.
-
(2010)
PLoS One
, vol.5
, Issue.11
-
-
Sjölinder, H.1
Jonsson, A.B.2
-
13
-
-
77957652922
-
The meningococcal vaccine candidate neisserial surface protein a (NspA) binds to factor H and enhances meningococcal resistance to complement
-
Lewis L.A., Ngampasutadol J., Wallace R., Reid J.E.A., Vogel L., Ram S. The meningococcal vaccine candidate neisserial surface protein a (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 2010, 6(7):e1001027.
-
(2010)
PLoS Pathog
, vol.6
, Issue.7
-
-
Lewis, L.A.1
Ngampasutadol, J.2
Wallace, R.3
Reid, J.E.A.4
Vogel, L.5
Ram, S.6
-
14
-
-
76849105930
-
Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease
-
Hill D.J., Griffiths N.J., Borodina E., Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond) 2010, 118(9):547-564.
-
(2010)
Clin Sci (Lond)
, vol.118
, Issue.9
, pp. 547-564
-
-
Hill, D.J.1
Griffiths, N.J.2
Borodina, E.3
Virji, M.4
-
15
-
-
0028348562
-
Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells
-
Nassif X., Beretti J.L., Lowly J., Stenberg P., O'Gaora P., Pfeifer J., et al. Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells. Proc Natl Acad Sci U S A 1994, 91:3769-3773.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 3769-3773
-
-
Nassif, X.1
Beretti, J.L.2
Lowly, J.3
Stenberg, P.4
O'Gaora, P.5
Pfeifer, J.6
-
16
-
-
0028808909
-
High adhesiveness of encapsulated Neisseria meningitidis to epithelial cells is associated with the formation of bundles of pili
-
Marceau M., Beretti J.L., Nassif X. High adhesiveness of encapsulated Neisseria meningitidis to epithelial cells is associated with the formation of bundles of pili. Mol Microbiol 1995, 17:855-863.
-
(1995)
Mol Microbiol
, vol.17
, pp. 855-863
-
-
Marceau, M.1
Beretti, J.L.2
Nassif, X.3
-
17
-
-
84887218070
-
Outer membrane biogenesis in E. coli, Neisseria meningitidis, and Helicobacter pylori; paradigm deviations in H. pylori
-
Liechti G., Goldberg J.B. Outer membrane biogenesis in E. coli, Neisseria meningitidis, and Helicobacter pylori; paradigm deviations in H. pylori. Front Cell Infect Microbiol 2012, 2(29):1-18.
-
(2012)
Front Cell Infect Microbiol
, vol.2
, Issue.29
, pp. 1-18
-
-
Liechti, G.1
Goldberg, J.B.2
-
18
-
-
0027524614
-
Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells
-
Virji M., Makepeace K., Ferguson D.J.P., Achtman M., Moxon E.R. Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol 1993, 10:499-510.
-
(1993)
Mol Microbiol
, vol.10
, pp. 499-510
-
-
Virji, M.1
Makepeace, K.2
Ferguson, D.J.P.3
Achtman, M.4
Moxon, E.R.5
-
19
-
-
0028284205
-
Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing polycitadine
-
Sarkari J., Pandt N., Moxon E.R., Achtman M. Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing polycitadine. Mol Microbiol 1994, 13:207-217.
-
(1994)
Mol Microbiol
, vol.13
, pp. 207-217
-
-
Sarkari, J.1
Pandt, N.2
Moxon, E.R.3
Achtman, M.4
-
20
-
-
31544449473
-
Prospects for vaccine prevention of meningococcal infection
-
Harrison L.H. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 2006, 19:142-164.
-
(2006)
Clin Microbiol Rev
, vol.19
, pp. 142-164
-
-
Harrison, L.H.1
-
21
-
-
0014531759
-
Human immunity to the meningococcus. I. The role of humoral immunity
-
Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral immunity. J Exp Med 1969, 129:1307-1326.
-
(1969)
J Exp Med
, vol.129
, pp. 1307-1326
-
-
Goldschneider, I.1
Gotschlich, E.C.2
Artenstein, M.S.3
-
22
-
-
0035112040
-
Serological basis for the use meningococcal serogroup C conjugate vaccine in the United Kingdom: reevaluation of correlates of protection
-
Borrow R., Andrews N., Goldblatt D., Miller E. Serological basis for the use meningococcal serogroup C conjugate vaccine in the United Kingdom: reevaluation of correlates of protection. Infect Immun 2001, 69(3):1568-1573.
-
(2001)
Infect Immun
, vol.69
, Issue.3
, pp. 1568-1573
-
-
Borrow, R.1
Andrews, N.2
Goldblatt, D.3
Miller, E.4
-
23
-
-
79960620598
-
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
-
Wang X., Cohn A., Comanducci M., Lubomira A., Zhao X., MacNeil J.R., et al. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine 2011, 29:4739-4744.
-
(2011)
Vaccine
, vol.29
, pp. 4739-4744
-
-
Wang, X.1
Cohn, A.2
Comanducci, M.3
Lubomira, A.4
Zhao, X.5
MacNeil, J.R.6
-
24
-
-
60549113322
-
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera
-
Granoff D.M., Welsch J.A., Ram S. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun 2009, 77:764-769.
-
(2009)
Infect Immun
, vol.77
, pp. 764-769
-
-
Granoff, D.M.1
Welsch, J.A.2
Ram, S.3
-
25
-
-
79251470393
-
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies
-
Seib K.L., Brunelli B., Brogioni B., Palumbo E., Bambini S., Muzzi A., et al. Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun 2011, 79:970-981.
-
(2011)
Infect Immun
, vol.79
, pp. 970-981
-
-
Seib, K.L.1
Brunelli, B.2
Brogioni, B.3
Palumbo, E.4
Bambini, S.5
Muzzi, A.6
-
26
-
-
77649265923
-
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
-
Serruto D., Spadafina T., Cuicchi L., Lewis L.A., Ram S., Tontini M., et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 2010, 107:3770-3775.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 3770-3775
-
-
Serruto, D.1
Spadafina, T.2
Cuicchi, L.3
Lewis, L.A.4
Ram, S.5
Tontini, M.6
-
27
-
-
84857443234
-
Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin a (Nad-A)-mediated adhesion and invasion
-
Montanari P., Bozza G., Capecchi B., Caproni E., Barrile R., Norais N., et al. Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin a (Nad-A)-mediated adhesion and invasion. Cell Microbiol 2012, 3:368-385.
-
(2012)
Cell Microbiol
, vol.3
, pp. 368-385
-
-
Montanari, P.1
Bozza, G.2
Capecchi, B.3
Caproni, E.4
Barrile, R.5
Norais, N.6
-
28
-
-
0037013966
-
NadA, a novel vaccine candidate for Neisseria meningitidis
-
Comanducci M., Bambini S., Brunelli B., Adu-Bobie J., Arico B., Capecchi B., et al. NadA, a novel vaccine candidate for Neisseria meningitidis. J Exp Med 2002, 195:1445-1454.
-
(2002)
J Exp Med
, vol.195
, pp. 1445-1454
-
-
Comanducci, M.1
Bambini, S.2
Brunelli, B.3
Adu-Bobie, J.4
Arico, B.5
Capecchi, B.6
-
29
-
-
0030775357
-
Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal OMV vaccine
-
van der Voort E.R., van Dijken H., Kuipers B., van der Biezen J., van der Ley P., Meylis J., et al. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal OMV vaccine. Infect Immun 1997, 12(5):5184-5190.
-
(1997)
Infect Immun
, vol.12
, Issue.5
, pp. 5184-5190
-
-
Van Der Voort, E.R.1
Van Dijken, H.2
Kuipers, B.3
Van Der Biezen, J.4
Van Der Ley, P.5
Meylis, J.6
-
30
-
-
74549212517
-
A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements
-
Metruccio M.M., Pigozzi E., Roncarati D., Scorza F., Norais N., Hill S.A., et al. A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements. PLoS Pathog 2009, 5:e1000710.
-
(2009)
PLoS Pathog
, vol.5
-
-
Metruccio, M.M.1
Pigozzi, E.2
Roncarati, D.3
Scorza, F.4
Norais, N.5
Hill, S.A.6
-
31
-
-
82355164193
-
Structure of the C-terminal domain of NHBA, on the main antigens of a novel vaccine against N. meningitidis
-
Esposito V., Musi V., de Chiara V., Veggi D., Serruto D., Scarselli M., et al. Structure of the C-terminal domain of NHBA, on the main antigens of a novel vaccine against N. meningitidis. J Biol Chem 2011, 286(48):41767-41775.
-
(2011)
J Biol Chem
, vol.286
, Issue.48
, pp. 41767-41775
-
-
Esposito, V.1
Musi, V.2
de Chiara, V.3
Veggi, D.4
Serruto, D.5
Scarselli, M.6
-
32
-
-
84861133426
-
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens
-
Serruto D., Bottomley M.J., Ram S., Giuliani M.M., Ruppuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 2012, 30:B87-B97.
-
(2012)
Vaccine
, vol.30
-
-
Serruto, D.1
Bottomley, M.J.2
Ram, S.3
Giuliani, M.M.4
Ruppuoli, R.5
-
33
-
-
0033028556
-
Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle?
-
Nassif X., Pujol C., Morand P., Eugene E. Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle?. Mol Microbiol 1999, 32(6):1124-1132.
-
(1999)
Mol Microbiol
, vol.32
, Issue.6
, pp. 1124-1132
-
-
Nassif, X.1
Pujol, C.2
Morand, P.3
Eugene, E.4
-
34
-
-
0032930533
-
Mutagenesis of the Neisseria porin reduces invasion in epithelial cells and enhances phagocyte responsiveness
-
Bauer F.J., Rudel T., Stein M., Meyer T.F. Mutagenesis of the Neisseria porin reduces invasion in epithelial cells and enhances phagocyte responsiveness. Mol Microbiol 1999, 31:903-913.
-
(1999)
Mol Microbiol
, vol.31
, pp. 903-913
-
-
Bauer, F.J.1
Rudel, T.2
Stein, M.3
Meyer, T.F.4
-
35
-
-
0029027169
-
Binding of syndecan like cell surface proteoglycan receptors is required for Neisseria gonorrheae entry into human mucosal cells
-
van Putten J.P., Paul S.M. Binding of syndecan like cell surface proteoglycan receptors is required for Neisseria gonorrheae entry into human mucosal cells. EMBO J 1995, 14:2144-2154.
-
(1995)
EMBO J
, vol.14
, pp. 2144-2154
-
-
Van Putten, J.P.1
Paul, S.M.2
-
36
-
-
84864147338
-
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomized, single-blind, placebo-controlled, phase 2 trial
-
Richmond P.C., Marshall H.S., Nissen M.D., Jiang Q., Jansen K.U., Garcés-Sanchéz M., et al. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomized, single-blind, placebo-controlled, phase 2 trial. Lancet 2012, 12:597-607.
-
(2012)
Lancet
, vol.12
, pp. 597-607
-
-
Richmond, P.C.1
Marshall, H.S.2
Nissen, M.D.3
Jiang, Q.4
Jansen, K.U.5
Garcés-Sanchéz, M.6
-
37
-
-
67349113150
-
Biology and pathogenesis of the evolutionary successful obligate human bacterium Neisseria meningitidis
-
Stephens D.S. Biology and pathogenesis of the evolutionary successful obligate human bacterium Neisseria meningitidis. Vaccine 2009, 27(Suppl. 2):B71-B77.
-
(2009)
Vaccine
, vol.27
, Issue.SUPPL. 2
-
-
Stephens, D.S.1
-
38
-
-
15544387941
-
Translocation and surface expression of lipidated serogroup B capsular polysaccharide in Neisseria meningitidis
-
Tzeng Y.L., Datta A.K., Strole C.A., Lobritz M.A., Carlson R.W., Stephens D.S. Translocation and surface expression of lipidated serogroup B capsular polysaccharide in Neisseria meningitidis. Infect Immun 2005, 73(3):1491-1505.
-
(2005)
Infect Immun
, vol.73
, Issue.3
, pp. 1491-1505
-
-
Tzeng, Y.L.1
Datta, A.K.2
Strole, C.A.3
Lobritz, M.A.4
Carlson, R.W.5
Stephens, D.S.6
-
39
-
-
0039313678
-
Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B
-
Frosch M., Weisgerber C., Meyer T.F. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci U S A 1989, 86(5):1669-1673.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, Issue.5
, pp. 1669-1673
-
-
Frosch, M.1
Weisgerber, C.2
Meyer, T.F.3
-
40
-
-
24644455976
-
Meningococcal infections at the start of the 21st century
-
Brandtzaeg P., van Deuren M. Meningococcal infections at the start of the 21st century. Adv Pediatr 2005, 52:129-162.
-
(2005)
Adv Pediatr
, vol.52
, pp. 129-162
-
-
Brandtzaeg, P.1
van Deuren, M.2
-
41
-
-
84857238470
-
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
-
Santolaya M.E., O'Ryan M.L., Valenzuela M.T., Prado V., Vergara R., Munoz A., et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 2012, 379:617-624.
-
(2012)
Lancet
, vol.379
, pp. 617-624
-
-
Santolaya, M.E.1
O'Ryan, M.L.2
Valenzuela, M.T.3
Prado, V.4
Vergara, R.5
Munoz, A.6
-
42
-
-
0345047706
-
Genetic basis for biosynthesis of the (Alpha1→4) linked N-acetyl-D-glucosamine-1-phosphate-capsule of the Neisseria meningitidis serogroup X
-
Tzeng Y.L., Noble C., Stephens D.S. Genetic basis for biosynthesis of the (Alpha1→4) linked N-acetyl-D-glucosamine-1-phosphate-capsule of the Neisseria meningitidis serogroup X. Infect Immun 2003, 71(12):6712-6720.
-
(2003)
Infect Immun
, vol.71
, Issue.12
, pp. 6712-6720
-
-
Tzeng, Y.L.1
Noble, C.2
Stephens, D.S.3
-
43
-
-
77952292205
-
Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis
-
Join-Lamber O., Morand P.C., Carbonnelle E., Coureuil M., Bille E., Bourdoulous S., et al. Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis. Prog Neurobiol 2010, 9(2):130-139.
-
(2010)
Prog Neurobiol
, vol.9
, Issue.2
, pp. 130-139
-
-
Join-Lamber, O.1
Morand, P.C.2
Carbonnelle, E.3
Coureuil, M.4
Bille, E.5
Bourdoulous, S.6
-
44
-
-
0014528516
-
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
-
Gotschlich E.C., Liu T.Y., Artenstein M.S. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med 1969, 129:1349-1365.
-
(1969)
J Exp Med
, vol.129
, pp. 1349-1365
-
-
Gotschlich, E.C.1
Liu, T.Y.2
Artenstein, M.S.3
-
45
-
-
33646839796
-
A review of vaccine research and development: meningococcal disease
-
Girard M.P., Preziosi M.P., Aguado M.T., Kieny M.P. A review of vaccine research and development: meningococcal disease. Vaccine 2006, 24:4692-4700.
-
(2006)
Vaccine
, vol.24
, pp. 4692-4700
-
-
Girard, M.P.1
Preziosi, M.P.2
Aguado, M.T.3
Kieny, M.P.4
-
46
-
-
34547927943
-
Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?
-
O'Brien K.L., Hochman M., Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?. Lancet Infect Dis 2007, 7:597-606.
-
(2007)
Lancet Infect Dis
, vol.7
, pp. 597-606
-
-
O'Brien, K.L.1
Hochman, M.2
Goldblatt, D.3
-
48
-
-
0035888124
-
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
-
Miller E., Salisbury D., Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2001, 20(Suppl. 1):S58-S67.
-
(2001)
Vaccine
, vol.20
, Issue.SUPPL. 1
-
-
Miller, E.1
Salisbury, D.2
Ramsay, M.3
-
49
-
-
77956164294
-
Meningococcal quadrivalent (serogroups A, C, W-135 and Y) conjugate vaccine (Menveo): in adolescents and adults
-
Deeks E.D. Meningococcal quadrivalent (serogroups A, C, W-135 and Y) conjugate vaccine (Menveo): in adolescents and adults. BioDrugs 2010, 24(5):287-297.
-
(2010)
BioDrugs
, vol.24
, Issue.5
, pp. 287-297
-
-
Deeks, E.D.1
-
50
-
-
84861315708
-
Protein conjugate polysaccharide vaccines: challenges in development and global implementation
-
Nair M. Protein conjugate polysaccharide vaccines: challenges in development and global implementation. Indian J Community Med 2012, 37(2):79-82.
-
(2012)
Indian J Community Med
, vol.37
, Issue.2
, pp. 79-82
-
-
Nair, M.1
-
51
-
-
0026410995
-
Meningococcal molecular mimicry and the search for an ideal vaccine
-
Griffiss J.M., Yamasaki R., Estabrook M., Kim J.J. Meningococcal molecular mimicry and the search for an ideal vaccine. Trans R Soc Trop Med Hyg 1991, 85(Suppl. 1):32-36.
-
(1991)
Trans R Soc Trop Med Hyg
, vol.85
, Issue.SUPPL. 1
, pp. 32-36
-
-
Griffiss, J.M.1
Yamasaki, R.2
Estabrook, M.3
Kim, J.J.4
-
52
-
-
0020518256
-
Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis
-
Finne J., Leinonen M., Mäkelä P.H. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 1983, 322(8346):355-357.
-
(1983)
Lancet
, vol.322
, Issue.8346
, pp. 355-357
-
-
Finne, J.1
Leinonen, M.2
Mäkelä, P.H.3
-
53
-
-
0030197579
-
Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
-
Peeters C.C., Rumke H.C., Sundermann L.C., van der Voort R., Meulenbelt E.M., Schuller J.M., et al. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 1996, 14:1009-1015.
-
(1996)
Vaccine
, vol.14
, pp. 1009-1015
-
-
Peeters, C.C.1
Rumke, H.C.2
Sundermann, L.C.3
van der Voort, R.4
Meulenbelt, E.M.5
Schuller, J.M.6
-
54
-
-
33748045136
-
Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine
-
Feiring B., Fuglesang J., Oster P., Naess L.M., Helland O.S., Tilman S., et al. Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine. Clin Vaccine Immunol 2006, 13:790-796.
-
(2006)
Clin Vaccine Immunol
, vol.13
, pp. 790-796
-
-
Feiring, B.1
Fuglesang, J.2
Oster, P.3
Naess, L.M.4
Helland, O.S.5
Tilman, S.6
-
55
-
-
70349406755
-
Phase II meningococcal B vesicle vaccine trial in New Zealand infants
-
Jackson C., Lennon D.R., Sotutu V.T., Yan J., Stewart J.M., Reid S., et al. Phase II meningococcal B vesicle vaccine trial in New Zealand infants. Arch Dis Child 2009, 10:745-751.
-
(2009)
Arch Dis Child
, vol.10
, pp. 745-751
-
-
Jackson, C.1
Lennon, D.R.2
Sotutu, V.T.3
Yan, J.4
Stewart, J.M.5
Reid, S.6
-
56
-
-
16544393141
-
The strategy to control New Zealand's epidemic of group B meningococcal disease
-
O'Hallahan J., Lennon D., Oster P. The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr Infect Dis J 2004, 23:S293-S298.
-
(2004)
Pediatr Infect Dis J
, vol.23
-
-
O'Hallahan, J.1
Lennon, D.2
Oster, P.3
-
57
-
-
14844296966
-
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
-
Oster P., Lennon D., O'Hallahan J., Mulholland K., Reid S., Martin D. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005, 23:2191-2196.
-
(2005)
Vaccine
, vol.23
, pp. 2191-2196
-
-
Oster, P.1
Lennon, D.2
O'Hallahan, J.3
Mulholland, K.4
Reid, S.5
Martin, D.6
-
58
-
-
33947575120
-
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
-
Oster P., O'Hallahan J., Aaberge I., Tilman S., Ypma E., Martin D. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. Vaccine 2007, 25:3075-3079.
-
(2007)
Vaccine
, vol.25
, pp. 3075-3079
-
-
Oster, P.1
O'Hallahan, J.2
Aaberge, I.3
Tilman, S.4
Ypma, E.5
Martin, D.6
-
59
-
-
35348995008
-
Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006
-
McNicholas A., Galloway Y., Stehr-Green P., Reid S., Radke S., Sexton K., et al. Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006. Hum Vaccine 2007, 3:196-204.
-
(2007)
Hum Vaccine
, vol.3
, pp. 196-204
-
-
McNicholas, A.1
Galloway, Y.2
Stehr-Green, P.3
Reid, S.4
Radke, S.5
Sexton, K.6
-
60
-
-
55249109216
-
Cuban meningococcal BC vaccine: experiences and contribution from 20 years of application
-
Padron S.F., Gill V.C., Diaz E.M.F., Valdespino E.D.C., Gotera N.G. Cuban meningococcal BC vaccine: experiences and contribution from 20 years of application. MEDICC Rev 2007, 9(1):16-22.
-
(2007)
MEDICC Rev
, vol.9
, Issue.1
, pp. 16-22
-
-
Padron, S.F.1
Gill, V.C.2
Diaz, E.M.F.3
Valdespino, E.D.C.4
Gotera, N.G.5
-
61
-
-
0035998867
-
Neisseria lactamica protects against experimental meningococcal infection
-
Oliver J.K., Reddin K.M., Bracegirdle P., Hudson M.J., Borrow R., Feavers I.M., et al. Neisseria lactamica protects against experimental meningococcal infection. Infect Immun 2002, 70(7):3621-3626.
-
(2002)
Infect Immun
, vol.70
, Issue.7
, pp. 3621-3626
-
-
Oliver, J.K.1
Reddin, K.M.2
Bracegirdle, P.3
Hudson, M.J.4
Borrow, R.5
Feavers, I.M.6
-
62
-
-
0034629284
-
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
-
Pizza M., Scarlato V., Masignani V., Guiliani M.M., Aricó B., Commanduci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287(5459):1816-1820.
-
(2000)
Science
, vol.287
, Issue.5459
, pp. 1816-1820
-
-
Pizza, M.1
Scarlato, V.2
Masignani, V.3
Guiliani, M.M.4
Aricó, B.5
Commanduci, M.6
-
63
-
-
0035925596
-
Reverse vaccinology, a genome-based approach to vaccine development
-
Rapuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001, 19(17-19):2688-2691.
-
(2001)
Vaccine
, vol.19
, Issue.17-19
, pp. 2688-2691
-
-
Rapuoli, R.1
-
64
-
-
0036714329
-
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarray
-
Grifantini R., Bartolini E., Muzzi A., Draghi M., Frigimelica E., Berger J., et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarray. Nat Biotechnol 2002, 20(9):914-921.
-
(2002)
Nat Biotechnol
, vol.20
, Issue.9
, pp. 914-921
-
-
Grifantini, R.1
Bartolini, E.2
Muzzi, A.3
Draghi, M.4
Frigimelica, E.5
Berger, J.6
-
65
-
-
67349114815
-
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis serogroup B
-
Holst J., Martin D., Arnold R., Huergo C.C., Oster P., O'Hallahan J., et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis serogroup B. Vaccine 2009, 27(Suppl. 2):B3-B12.
-
(2009)
Vaccine
, vol.27
, Issue.SUPPL. 2
-
-
Holst, J.1
Martin, D.2
Arnold, R.3
Huergo, C.C.4
Oster, P.5
O'Hallahan, J.6
-
66
-
-
0033831758
-
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States: the active bacterial core surveillance team
-
Tondella M.L., Popovic T., Rosensetin N.E., Lake D.B., Carlone G.M., Mayer L.W., et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States: the active bacterial core surveillance team. J Clin Microbiol 2000, 38:3323-3328.
-
(2000)
J Clin Microbiol
, vol.38
, pp. 3323-3328
-
-
Tondella, M.L.1
Popovic, T.2
Rosensetin, N.E.3
Lake, D.B.4
Carlone, G.M.5
Mayer, L.W.6
-
67
-
-
33746829277
-
Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States
-
Borrow R., Carlone G.M., Rosenstein N., Blake M., Feavers I., Martin D., et al. Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States. Vaccine 2006, 24:5093-5107.
-
(2006)
Vaccine
, vol.24
, pp. 5093-5107
-
-
Borrow, R.1
Carlone, G.M.2
Rosenstein, N.3
Blake, M.4
Feavers, I.5
Martin, D.6
-
68
-
-
33746593691
-
A universal vaccine for serogroup B meningococcus
-
Giuliani M.M., Adu-Bobie J., Comanducci M., Aricò B., Savino S., Santini L., et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 2006, 103:10834-10839.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 10834-10839
-
-
Giuliani, M.M.1
Adu-Bobie, J.2
Comanducci, M.3
Aricò, B.4
Savino, S.5
Santini, L.6
-
69
-
-
0037451178
-
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
-
Masignani V., Comanducci M., Giuliani M.M., Aricó B., Savino S., Santini L., et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 2003, 197:789-799.
-
(2003)
J Exp Med
, vol.197
, pp. 789-799
-
-
Masignani, V.1
Comanducci, M.2
Giuliani, M.M.3
Aricó, B.4
Savino, S.5
Santini, L.6
-
70
-
-
64449085566
-
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
-
Bambini S., Muzzi A., Olcen P., Rappuoli R., Pizza M., Commanduci M. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 2009, 27:2794-2803.
-
(2009)
Vaccine
, vol.27
, pp. 2794-2803
-
-
Bambini, S.1
Muzzi, A.2
Olcen, P.3
Rappuoli, R.4
Pizza, M.5
Commanduci, M.6
-
71
-
-
70449632740
-
Characterisation of fHbp, NHBA (GNA2132), NadA, PorA, sequence type and the genomic presence of IS1301 in group B meningococcal ST269 clonal complex case-isolates from England and Wales
-
Lucidarme J., Comanducci M., Findlow J., Gray S.J., Kaczmarski E.B., Guiver M., et al. Characterisation of fHbp, NHBA (GNA2132), NadA, PorA, sequence type and the genomic presence of IS1301 in group B meningococcal ST269 clonal complex case-isolates from England and Wales. J Clin Microbiol 2009, 47(11):3577-3585.
-
(2009)
J Clin Microbiol
, vol.47
, Issue.11
, pp. 3577-3585
-
-
Lucidarme, J.1
Comanducci, M.2
Findlow, J.3
Gray, S.J.4
Kaczmarski, E.B.5
Guiver, M.6
-
72
-
-
77954761297
-
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
-
Giuliani M.M., Biolchi A., Serruto D., Ferlicca F., Vienken K., Oster P., et al. Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus. Vaccine 2010, 28(31):5023-5030.
-
(2010)
Vaccine
, vol.28
, Issue.31
, pp. 5023-5030
-
-
Giuliani, M.M.1
Biolchi, A.2
Serruto, D.3
Ferlicca, F.4
Vienken, K.5
Oster, P.6
-
73
-
-
2142828652
-
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine
-
Welsch J.A., Comanducci M., Granoff D.M. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J Immunol 2004, 172(9):5606-5615.
-
(2004)
J Immunol
, vol.172
, Issue.9
, pp. 5606-5615
-
-
Welsch, J.A.1
Comanducci, M.2
Granoff, D.M.3
-
74
-
-
0020684912
-
Human insulin from recombinant DNA technology
-
Johnson I.S. Human insulin from recombinant DNA technology. Science 1983, 219(4585):632-637.
-
(1983)
Science
, vol.219
, Issue.4585
, pp. 632-637
-
-
Johnson, I.S.1
-
75
-
-
84856773073
-
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
-
Grossger N., Snape M.D., Yu L.M., Finn A., Bona G., Esposito S., et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. J Am Med Assoc 2012, 8(6):573-582.
-
(2012)
J Am Med Assoc
, vol.8
, Issue.6
, pp. 573-582
-
-
Grossger, N.1
Snape, M.D.2
Yu, L.M.3
Finn, A.4
Bona, G.5
Esposito, S.6
-
76
-
-
84874794545
-
-
Who would have ever thought a vaccine to protect babies' brains could be a tough sell? Forbes Web [accessed 12/2012].
-
Herper M. Who would have ever thought a vaccine to protect babies' brains could be a tough sell? Forbes Web [accessed 12/2012]. http://www.forbes.com/sites/matthewherper/2012/02/24/who-would-have-ever-thought-a-vaccine-to-protect-babies-brains-could-be-a-tough-sell/.
-
-
-
Herper, M.1
-
77
-
-
22644433305
-
Complement escape of human pathogenic bacteria y acquisition of complement regulators
-
Kraiczy P., Wurzner R. Complement escape of human pathogenic bacteria y acquisition of complement regulators. Mol Immunol 2006, 43(1-2):31-44.
-
(2006)
Mol Immunol
, vol.43
, Issue.1-2
, pp. 31-44
-
-
Kraiczy, P.1
Wurzner, R.2
-
78
-
-
67650691544
-
Sequence diversity of vaccine candidate LP2086 in epidemiologically relevant strains of serogroup B Neisseria meningitidis
-
Murphy E., Andrew L., Lee L.K., Dilts D., Ambrose K., Borrow R., et al. Sequence diversity of vaccine candidate LP2086 in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infec Dis 2009, 200(3):379-389.
-
(2009)
J Infec Dis
, vol.200
, Issue.3
, pp. 379-389
-
-
Murphy, E.1
Andrew, L.2
Lee, L.K.3
Dilts, D.4
Ambrose, K.5
Borrow, R.6
-
79
-
-
85074864438
-
-
Vaccines, Saunders-Elsevier, Philadelphia, p. 399-434
-
Granoff D.M., Harrison L.H., Borrow R. Meningococcal vaccines 2008, Vaccines, Saunders-Elsevier, Philadelphia, p. 399-434. 5th ed.
-
(2008)
Meningococcal vaccines
-
-
Granoff, D.M.1
Harrison, L.H.2
Borrow, R.3
-
80
-
-
12144290906
-
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
-
Fletcher L.D., Bernfield L., Barniak V., Farley J.E., Howell A., Knauf M., et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 2004, 72(4):2088-2100.
-
(2004)
Infect Immun
, vol.72
, Issue.4
, pp. 2088-2100
-
-
Fletcher, L.D.1
Bernfield, L.2
Barniak, V.3
Farley, J.E.4
Howell, A.5
Knauf, M.6
-
81
-
-
1842427187
-
Identification of a novel vaccine candidate for group B Neisseria meningitidis
-
Bernfield L., Fletcher L.D., Pizza M., Rappuoli R., Ratti G., et al. Identification of a novel vaccine candidate for group B Neisseria meningitidis. Proceedings of the 13th international pathogenic neisseria conference. Oslo, Norway 2002, 116.
-
(2002)
Proceedings of the 13th international pathogenic neisseria conference. Oslo, Norway
, pp. 116
-
-
Bernfield, L.1
Fletcher, L.D.2
Pizza, M.3
Rappuoli, R.4
Ratti, G.5
-
83
-
-
84874691273
-
Potential impact of the bivalent Rlp2086 vaccine on Neisseria meningitidis invasive disease and carriage isolates in two adolescent populations
-
Epub ahead of print
-
Anderson A., Hao L., Jiang Q., Harris S.L., Jones T.R., Perez J.L., et al. Potential impact of the bivalent Rlp2086 vaccine on Neisseria meningitidis invasive disease and carriage isolates in two adolescent populations. Hum Vaccin Immunother 2012, 9(3). Epub ahead of print.
-
(2012)
Hum Vaccin Immunother
, vol.9
, Issue.3
-
-
Anderson, A.1
Hao, L.2
Jiang, Q.3
Harris, S.L.4
Jones, T.R.5
Perez, J.L.6
-
84
-
-
0042090321
-
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential
-
Vandeputte-Rutten L., Bos M.P., Tommassen J., Gros P. Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J Biol Chem 2003, 278:24825-24830.
-
(2003)
J Biol Chem
, vol.278
, pp. 24825-24830
-
-
Vandeputte-Rutten, L.1
Bos, M.P.2
Tommassen, J.3
Gros, P.4
-
85
-
-
0034730705
-
Candidate Neisseria meningitidis NspA vaccine
-
Martin D., Brodeur B.R., Harnel J., Couture F., de Alwis U., Lian Z., et al. Candidate Neisseria meningitidis NspA vaccine. J Biotechnol 2000, 83(1-2):27-31.
-
(2000)
J Biotechnol
, vol.83
, Issue.1-2
, pp. 27-31
-
-
Martin, D.1
Brodeur, B.R.2
Harnel, J.3
Couture, F.4
de Alwis, U.5
Lian, Z.6
|